chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Acute icshemic stroke (basilar artery thrombus).  Underwent mechanical thrombectomy 11/25/08.  2/2/09 Received ER medical records of 11/19/2008. FINAL DX: acute non-specific HA Records reveal patient experienced worsening HA x 5 days w/cloudy vision left eye, fatigue, irritability & nausea.  Had been seen by PCP 2 days prior & dx w/left otitis media.  Tx w/oral antibiotics.  Exam in ER was WNL & tx w/IVF & IV meds.  Improved & d/c to home.  2/3/09 Received PCP office records of 11/17/08-1/18/2009. FINAL DX: left OM w/viral URI Records reveal patient experienced left eye vision deficit, decreased hearing left ear, left side headache, decreased appetite & energy.  Tx w/oral antibiotics & would refer to Ophtho if s/s persisted.  RTC 11/21 s/p ER visit w/URI & OM resolving.  RTC 11/22 w/persistent but intermittent HA & had missed school.  OM had resolved but tx w/oral antibiotics.  Referred for MRI.  RTC 1/12/09 s/p recent hospitalization for acute ischemic stroke with basilar artery thrombus occlusion s/p mechanical thrombectomy on 11/25/08  & having vomiting.  Sent for urgent MRI.  RTC 1/15/09 for conference.  2/09/09 Received hospital medical records of 11/24-12/3/2008. FINAL DX: acute ischemic stroke, basilar artery thrombus occlusion w/resultant bilateral posterior circulation strokes; s/p mechanical thrombectomy 11/25/08. D/C Summary mixed in with records which reveal patient had been transferred to PICU from outlying ER.  Patient experienced retroorbital eye pain & HA x 10 days prior to admit.  One week prior to admit had trouble catching ball from left side.  Five days prior to admit had severe HA behind left eye.  One day prior to admit had dizziness, vomiting, peripheral vision loss but no pain.  On day of admit, had generalized pain, abnormal behavior, talking nonsense, incomplete sentences.  Deficits at d/c included: right arm dysmetria w/minimal weakness, LLE dysmetria, quandrantanopia, dysarthria & left side sensory deficit, required assist to walk due to incoordination.  D/C to inpatient rehab on continued ASA.  was to f/u w/peds neuro & ophtho when d/c from rehab & to have repeat labs.  Neuro. Ophtho clinic notes of 2/3/2009.  Doing well & had returned to school.  Reading speed was significantly slower but otherwise approx same level as prior to stroke.  Had developed behavior issues w/hyperactivity & outbursts. Visual fields deficits.  2/17/09 Received ER records of 11/23 & 11/24/2008. FINAL DX: right occipital lobe AV malformation; acute ischemic stroke left occipital lobe; altered mental status secondary to above; leukocytosis secondary to above. Pt transferred by ambulance due to inclement weather to higher level of care.  Incomplete homonymous hemianopsia, behaviour problems.
Hot flashes, rash on face, shaking, runny nose, sweating, fever, body aches.
100-500 diffuse papule-vesicular pruritic rash w/characteristics of varicella; typical pattern of appearance and distribution, NOT as pruritic as typical varicella
Patient received vaccine at around 12:00 noon of 9/19/2023, this vaccine was given by another nurse. Patient notified office today 9/20/23 regarding reactions she felt last night after receiving the flu vaccine. Patient report night of 9/19/23 at about 9:30pm  she felt left arm pain that she rates a 6-7 in a scale of 1-10 and stiffness to her neck, denies any other reaction. Patient took Tylenol 1000mg by mouth night of 9/19/23 at around 11:00pm and another dose of Tylenol 1000mg morning of 9/20/2023 at around 5:30am.
Pt tested + for Covid during hospitalization. Asymptomatic at this time. Pt states that he is fully vaccinated against covid. Dates and manufacturer info unable to be obtained at this time.
Covid Arm; itchy rash; little knot there; Red rash; HR increased; BP increased; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (HR increased), BLOOD PRESSURE INCREASED (BP increased), VACCINATION SITE RASH (Covid Arm), RASH PRURITIC (itchy rash) and VACCINATION SITE INDURATION (little knot there) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products Los for an unknown indication and INSULIN LISPRO (HUMALOG) for an unknown indication.    Concurrent medical conditions included Diabetes, Hypertension, High cholesterol and Asthma.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started Los (unknown route) at an unspecified dose and INSULIN LISPRO (HUMALOG) (unknown route) at an unspecified dose. On 17-Jan-2021, the patient experienced HEART RATE INCREASED (HR increased) and BLOOD PRESSURE INCREASED (BP increased). On 27-Jan-2021, the patient experienced VACCINATION SITE RASH (Covid Arm), RASH PRURITIC (itchy rash), VACCINATION SITE INDURATION (little knot there) and RASH ERYTHEMATOUS (Red rash ). At the time of the report, HEART RATE INCREASED (HR increased) and BLOOD PRESSURE INCREASED (BP increased) had resolved and VACCINATION SITE RASH (Covid Arm), RASH PRURITIC (itchy rash), VACCINATION SITE INDURATION (little knot there) and RASH ERYTHEMATOUS (Red rash ) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: No specific follow-up information recorded.
I didn't even know I had COVID-19 but I was having sinus problems a little worse than usual.  A person I had come in contact with told me that she was COVID-19 positive so I tested myself and I was positive.
Vesicular rash- dx chickenpox/varicella on 11/2/05 temp 100F. Back, face, warm legs.
This spontaneous case, initially received on 20-Oct-2016, was reported by a health professional and concerns a 27-year-old female patient. Weight: not provided; Height: not provided. Concomitant medication: not reported. Administration of company suspect drug(s): The patient received AFLURIA from 17-OCT-2016 to 17-OCT-2016. Dose regimen: 0.5 ml, Route of administration: Intramuscular. Batch number: WT51905. No additional suspect drugs. Adverse event description: On 17-Oct-2016, temperature excursion, syringe was administered to a patient (outcome: not reported, special circumstances: drug administration error without adverse event). The PFS (pre-filled syringe) was out of range for 72 hours. Maximum 51 degrees Fahrenheit (10.56 degrees Celsius). The facility has since discarded all other PFS affected. Reporter comments: The healthcare professional considered the event non-serious.
Information has been received from a physician concerning a child who was vaccinated with a dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella Virus Vaccine live (upgrade process). Subsequently, the patient developed swelling at the injection site. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Pt reported that she developed  fever, fatigue and severe pain in her legs, and had to be life flighted and admitted into a hospital for 3 weeks.  She is now out of the hospital, but continues getting treatments for her legs.  Her legs are swollen and bandaged.   Since vaccination pt had to get on blood thinners , diuretics and  multiple other medications to control her symptoms.   Her condition has improved, but she is not back to normal.
Woke up the next morning feeling sore at shot site and as the day progressed my body started to ache all over.  For the next 2 days after this, I will alternate between having the chills and having intense sweats.  On Friday 06/25/2021, I woke up to my chest hurting , I could not catch my breath, it felt like I had a very heavy weight on my chest .  I went to the emergency room which is a part of the Hospital.  After the initial tests the  physician told me with 99% certainty that I had had a heart attack.  Soon after this they rushed me by ambulance from hospital to hospital which is about 20 miles or so.  They rushed me in and completed an arteriogram within minutes of arriving at the hospital.  They confirmed with this test that is was not a heart attack and after several more test, the doctor that I had developed Myocarditis due to the vaccine shot.  The admitted me into the hospital on 06/25/2021 for observation and to run more test until I was stable enough to go home.  I stayed in the hospital for 1 evening and was discharged on 06/26/2021 at about 1:00 or 2:00 that afternoon.  The doctor prescribed several medications for me to take for my heart for the next foreseeable future.  On 06/30/2021 I had a visit to my new cardiologist in which he ran several test and stating that I was looking better, but he had ordered an MRI to take place on 07/06/2021 at Hospital.  I have a follow up visit for my cardiologist slated for 07/19/2021 in which I will find out more information.
I wasn?t able to eat or drink for at least 3 days, throwing up a lot. Diarrhea after that after 4 days. My main concern is I started hearing and seeing things on day 3 after the vaccine. I?m not sure if it was from dehydration or ? It lasted about 24 hours. It was pretty intense at times. I got scared. My dreams were very scary as well.  I?m wondering is this something that could of caused this reaction? It got as bad as I felt someone was in my house and I was sleep walking..  my next shot will be the 28th or 29th.  Thoughts?
This case was reported by a healthcare professional and described the occurrence of allergic reaction in a subject of unspecified age and gender who was vaccinated with influenza (GlaxoSmithKline). On 18 October 2013 the subject received a dose of influenza (unknown details). It was unclear from the report if the subject received trivalent or quadrivalent formulation. On 18 October 2013, 30 minutes after vaccination with influenza, the subject experienced allergic reaction. No further details were provided. At the time of reporting the outcome of the event was unspecified. Follow-up information was received on 25 November 2013 via nurse who reported the 24-year-old female subject was vaccinated with FLULAVAL (.5 ml, intramuscular, unknown deltoid) on 18 October 2013. On 18 October 2013, 30 minutes after vaccination with FLULAVAL, the subject experienced allergic reaction; symptoms included urticaria, dizziness and hypertension. The nurse reported the subject got light headed about 30 minutes post injection with FLULAVAL. Her blood pressure was 150/70 and she got hives. She was treated at the emergency room with steroids and discharge home on prednisone and BENADRYL. The subject had not previously received FLULAVAL; it was withdrawn and not reintroduced. On 25 October 2013, the events were resolved and the subject made a full recovery. The subject took steroids for four to five days post event. The reporting healthcare professional considered the events serious such as clinically significant (or requiring intervention), as well as potentially life threatening.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. In August 2016, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). In January 2017, the patient was treated by a healthcare provider at an urgent care for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries.  As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Patient was sleeping and awoke to an uncontrollable shake through entire body. He states he stood up and his legs felt very heavy and continued to shake about 10-15 seconds. He is scheduled to see his doctor this morning as a follow up. The patient also mentions he had a CAT scan with contrast earlier the same day (Monday 5/3).
death J18.9 - Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung
Swelling, redness, soreness, itchy at injection site, hoarseness, wheezing, treated with Benadryl and Albuterol.
HEART PALPITATIONS HEART BEATING RAPIDLY DIFFICULTY BREATHING COULD NOT CLIMB STAIRS FEELING LIKE BIG EXPLOSIONS IN MY CHEST. THEY STARTED AT 11:45AM  TWO HOURS AFTER DOSE  STILL EXPERIENCING PAIN. WENT TO MY CARDIOLOGIST 4/8/2021 AFTER IST VACCINE. HE MADE TEST SAID I WAS FINE.
The mother of patient reported he was having vomiting to the pharmacy technician who then passed the call to the pharmacist.  The mother reported swelling of the face to the pharmacist.  Pharmacist told parent to seek emergency medical attention.  The mother said she was taking the patient to the emergency room.
I developed a rash on the backside of of my right arm accompanied with fever 18 hours after injection. Went to a clinic 2 days after inject and was diagnosed with cellulitis. The attending NP suggested I submit a report even though it may be unrelated. Was prescribed 10 days, 4x per day, 500 mg cephalexin (KEFLEX) this was the second injection and there were no known issues with the first injection.
1 of 2 pts who w/in 48 hrs postimmunization exp cellulitis @ the inject site; reaction included 4cm of erythema, induration & tenderness; treated w/Floxin 400mg BID x 5 days;
This case was reported by a consumer via call center representative and described the occurrence of burning skin in a 23-year-old female patient who received RABAVERT (batch number 628011A, expiry date 30th April 2020). The patient's past medical history included animal bite (she was bitten on her back by a bat). Concomitant products included RABAVERT. On 16th November 2017, the patient received the 2nd dose of RABAVERT. On an unknown date, the dose was an unknown dose.  On 16th November 2017, less than an hour after receiving RABAVERT, the patient experienced burning skin and lacrimation. On an unknown date, the patient experienced inappropriate preparation of medication. On an unknown date, the outcome of the burning skin was recovered/resolved and the outcome of the lacrimation and inappropriate preparation of medication were unknown. The reporter considered the burning skin and lacrimation to be related to RABAVERT. Additional details were reported as follows: On 16th November 2017 the patient received RABAVERT which led to the occurrence of inappropriate reconstitution technique. In less than an hour after the patient received RABAVERT she experienced burning skin and lacrimation. The caller stated that the nurse gave the patient a part of the vaccine in her left arm, which burned extremely bad bringing her to tears. She states then the nurse stated she didn't see another part of the vaccine and proceeded to give her another part in her right arm. She stated the two were spaced about 15 minutes apart. The vaccine was given at an infusion center within the hospital.
Next day, post vaccine 8am, I woke up with mild headache and sore throat. At around 10am, I got really sleepy and tired. I started feeling chills and at around 1pm I felt really hot. I took my temperature and it was 99.9F. I pretty much slept all day. The next day 11/15, I still didn't feel well, I still had headache, sore throat, and joints especially hips and knees felt like on fire. I called in sick to work. On 11/16, I continued with these symptoms, but also developed nausea and poor appetite. I work from home, but I was very tired and around 12pm I felt hot and my Temp was 99.5F. I completed an E-visit with pcp and a COVID test was ordered. My symptoms are better, but I still don't feel well, my head feels funny, I have mild sore throat, and my body and joints are achy. I did get a note from pcp to be off work this week.  I feel very fatigued and for the last 2 days, I have had temp of 99.3-99.5 F around 3pm, but my body feels like if it were much hotter.
patient inadvertently received moderna vaccine. no side effects noted. parent notified. contacted moderna and they stated that 16-17 yr olds per CDC can receive 2nd dose of moderna if inadvertently given as 1st dose.
What happened was the MA, drew up Proquad, Proquad diluent, and Varivax (all on one syringe) and it was administered to the patient. A double check was done by MA, but not until they were already drawn up. At that point it was labeled MMRV so MA thought it was Proquad. I contact agency and spoke with staff @ 1413. I told her the situation and she said that the patient got an extra dose of varicella. She advised we call the parents and discuss the following: There is an increased risk of febrile seizures with the additional dose of varicella. Watch for fevers and give acetaminophen and/or ibuprofen to reduce fevers as needed.  Staff will contact the patients parent and discuss.
My hands are ice cold and feel nauseated. Stomach doesn't feel good - don't want to eat.  Left arm is sore.
Hives to both H1N1 & seasonal flu injection. Has never been allergic to eggs. Reaction greater on R side to H1N1 vaccine. Treatment with Benadryl & Claritin.
Lightheaded ness, fever, chills, body aches, severe ?covid arm? - rash on injection sight about 2in in diameter
Soon after injection, during observation period, became sob, had some coughing and felt like throat was closing. Sent to ED. Received diphenhydramine 25mh, epi 0.3, famotidine 20 mg, methylprednisolone 125mg and albuterol inhaler. improved and sent home.
Vision loss in tunnel fashion for about 15 minutes, legs gave way and I collapsed onto the ground.
I had to use my walker, from knee surgery 2 yrs ago, to get around. Still difficult- legs and knees hurt pretty bad. Husband said I was ?talking out of my head some?, was very tired. It passed after one day.  *Please make note that I did have Covid in January- in my lungs. I did not report to my dr- but I will
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 03-AUG-2015, the patient was inoculated with ZOSTAVAX at a family physician's office, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 26-FEB-2016, the patient was treated at the family physician's office for the onset of severe vesicular rash accompanied weakened immune symptoms, which was diagnosed as severe herpes zoster and Bell's palsy, a condition of nerve damage affecting the facial muscles. She was prescribed acyclovir and gabapentin for management of her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcomes of the events were unknown at the time of reporting. Causality assessment was related. Upon internal review, Bell's palsy was considered medically significant. Additional information has been requested.
Itching and rash which was severe enough that the next day, I sought treatment at the Physicians Immediate Care.  I was prescribed 20 mg of Prednisone, Benadryl
flu symptoms; DVT; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 19Apr2021 (Lot number: EW0158) at the age of 51 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, lot number: ER8733), administration date: 29Mar2021, when the patient was 51 years old, for COVID-19 immunization. The following information was reported: INFLUENZA (life threatening) with onset 02Aug2021, outcome "recovered with sequelae", described as "flu symptoms "; DEEP VEIN THROMBOSIS (life threatening) with onset 02Aug2021, outcome "recovered with sequelae", described as "DVT". The events "flu symptoms " and "dvt" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of influenza, deep vein thrombosis (Blood thinners). No follow-up attempts are possible. No further information is expected.
COMPLAINING OF PAIN AND TENDERNESS SINCE INJECTION, PAINFUL TO RAISE ARM OR LAY ON ARM.STATES ARM WAS SWOLLEN AND RED AFTER INJECTION FOR AND CONTINUES OFF AND ON TIL NOW.  USES TOPICAL RUB FOR DISCOMFORT.
Patient received the Boostrix first with no reactions. Patient then received the Engerix-B vaccine and commented that he could "feel" that one more than the other. Soon after him saying that he slumped forward in his chair and was unresponsive for what seemed like less than 30 seconds. Patient then came to, but seemed foggy mentally and was lethargic. EMS was called and patient was taken to the ER.
described lt side face swelling-brusing to upper cheek & jaw-some rt side swelling onset eve of recving vax; instructed to consult MD for treatment & cont of HEP series;
Extreme heat, sweating, light-headedness, black spots/sight going, buckled knees, hearing gone in left ear and then both ears, unconsciousness-- told husband when I began sweating and getting light-headedness, he held my body weight and helped me to the ground safely, friend held my head, husband lifted legs until I regained consciousness, help escort me to a place I could sit down, EMT provided cold water bottle to wrists, cold cloth was provided, sat with legs elevated until feeling stable